<DOC>
	<DOCNO>NCT02552537</DOCNO>
	<brief_summary>In patient walnut allergy double blind placebo control food challenge walnut combine intake proton pump inhibitor ( PPI ) placebo assess impact PPI threshold level clinical manifestation .</brief_summary>
	<brief_title>iFAAM : The Impact Proton-pump Inhibitors ( Antacids ) Threshold Dose Distributions</brief_title>
	<detailed_description>1. detailed case history , blood sample prick test different food perform . 2. double blind food provocation three meal contain either placebo walnut walnut allergic patient perform . 3. provocation combine intake drug ( omeprazole ) placebo ( mannitol ) blind capsule .</detailed_description>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Food Hypersensitivity</mesh_term>
	<mesh_term>Mannitol</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<mesh_term>Antacids</mesh_term>
	<criteria>sign informed consent , history walnut allergy , minimum age 18 year â€¢ Known hypersensitivity allergy Omeprazole , proton pump inhibitor , mannitol , ingredient placebo meal Drugs allow study due prove interaction Omeprazole : Digoxin , Clopidogrel , Methotrexate , Antiretroviral drug , Diazepam , Cilostazol , Phenytoin , Warfarin ( RWarfarin ) Vitamin K antagonist , Phenytoin , Tacrolimus , Clarithromycin , voriconazole , Rifampicin Hypericum Drugs allow due interference food challenge ( short interval last treatment food challenge ) corticosteroid systemically ( 2 week ) antihistamine ( 3 day ) except hydroxyzine ( 10 day ) ketotifen ( 2 week ) betablocker ( 1 day ) angiotensin convert enzyme ( ACE ) inhibitor ( 2 day ) omalizumab ( 2 month ) Women pregnant breast feed Intention become pregnant course study Lack safe contraception , define : female participant childbearing potential , use willing continue use medically reliable method contraception entire study duration , oral , injectable , implantable contraceptive , intrauterine contraceptive device Please note female participant surgically sterilise / hysterectomised postmenopausal longer 2 year consider child bear potential . Uncontrolled asthma , force expiratory volume &lt; 70 % predict value Acute allergic disease Chronic urticaria Mastocytosis Other clinically significant concomitant disease state ( major organic infectious disease , e.g. , renal failure , hepatic dysfunction , cardiovascular disease , acute febrile infection ) , Known suspect noncompliance , drug alcohol abuse , Inability follow procedure study , e.g . due language problem , psychological disorder , dementia , etc . participant , Participation another study investigational drug within 30 day precede present study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>